
In the pilot clinical trial of 150 patients undergoing coronary artery bypass grafting (CABG) using radial artery (RA) grafts, nicorandil and isosorbide mononitrate were associated with lower RA graft failure rates compared to diltiazem at both 1 and 24 weeks. At 24 weeks, RA graft failure was 16.1% for nicorandil and 12.5% for isosorbide mononitrate, compared to 27.8% for diltiazem. These findings suggest that nicorandil and isosorbide mononitrate may more effectively prevent RA graft failure post-CABG.
Like
Save
Share